Scarica l'app Stockscreener
11.00
1.85%
0.20
Dopo l'orario di chiusura:
11.05
0.05
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IOVA Giù?
Forum
Previsione
Frazionamento azionario
Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie
Iovance Biotherapeutics, Inc. (IOVA) Options Chain - Yahoo! Finance Canada
IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism - Stocktwits
Iovance Biotherapeutics stock hits 52-week high at 10.98 USD - Investing.com
Iovance Biotherapeutics Price Target Announced at $15.00/Share by Goldman Sachs - Moomoo
After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - Stocktwits
Why Iovance Biotherapeutics Stock Was on Fire Today - The Globe and Mail
IOVA Reinstated by Goldman Sachs -- Buy Rating with Price Target of $15.00 - GuruFocus
Goldman Sachs Reinstates Buy on Iovance Biotherapeutics (IOVA) w - GuruFocus
IOVA Stock Quote Price and Forecast - CNN
Iovance Biotherapeutics, Inc. (IOVA) stock price, news, quote and history - Yahoo Finance UK
Iovance Biotherapeutics, Inc. (IOVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
IOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - Stocktwits
Iovance Biotherapeutics Inc (IOVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Iovance Biotherapeutics stock extends rally after strong earnings and cancer therapy momentum - AD HOC NEWS
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research
Iovance Biotherapeutics Stock: 6 Straight Green Days, Up 26% - Trefis
Why Did Iovance Biotherapeutics (IOVA) Move Today? - Yahoo Finance
Iovance Biotherapeutics (IOVA) Is Up 19.2% After Record Q2 Amtagvi Revenue And TIL Pipeline Expansion - Yahoo Finance
Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress - Yahoo Finance
Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales? - Yahoo Finance
Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Moomoo
Iovance Biotherapeutics (IOVA) Stock Forum and Discussion - Moomoo
Iovance Biotherapeutics (IOVA) Puts Buyer Nets 64% Gain as Marke - GuruFocus
Iovance Biotherapeutics (IOVA) Stock Analysis: Unpacking the 65.7% Revenue Growth Potential - DirectorsTalk Interviews
$Iovance Biotherapeutics (IOVA.US)$ - Moomoo
$Iovance Biotherapeutics (IOVA.US)$ Talking a profit here and waiting for it to come down closer to 9 ema - Moomoo
IOVA Maintained by Barclays -- Price Target Raised to $15.00 - GuruFocus
Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Raises Target Price to $15 - Moomoo
IOVA Stock Has Gained More Than 21% In Four Sessions, And Barclays Sees Another 52% Upside PotentialHere’s Why - finance.yahoo.com
Iovance Biotherapeutics stock hits 52-week high at 9.36 USD By Investing.com - Investing.com Nigeria
Iovance Biotherapeutics stock hits 52-week high at 9.36 USD - Investing.com
Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - Stocktwits
Why Did IOVA Stock Gain Pre-Market Today? - Stocktwits
Iovance Biotherapeutics' Chief Regulatory Officer Reports RSU Vesting and Tax Withholding Transactions - Kalkine Media
Iovance at Wells Fargo conference: sales momentum lifts outlook By Investing.com - Investing.com Australia
Iovance Biotherapeutics (IOVA) Slips 3.10% to $8.43 as Support at $8.01 Comes Into FocusAlgorithmic Stock Picks - careplusvn.com
Iovance Biotherapeutics stock trends on sector momentum, Q2 beat - scanx.trade
Why Is IOVA Stock Falling Today? - Stocktwits
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
How Iovance Biotherapeutics Inc. (IOVA) Affects Rotational Strategy Timing - Stock Traders Daily
Iovance Biotherapeutics Stock Price Forecast. Should You Buy IOVA? - StockInvest.us
Iovance Biotherapeutics, Inc. (IOVA) Latest Press Releases & Corporate News - Yahoo Finance
Iovance Biotherapeutics, Inc. (IOVA) Latest Stock News & Headlines - Yahoo Finance
Iovance Biotherapeutics to Present at Upcoming Conferences - The Manila Times
Iovance Biotherapeutics (IOVA) Stands Out with Strong Quant Rati - GuruFocus
Iovance Biotherapeutics (IOVA) Wins FDA Trial Clearance, Is The Stock Still 54% Undervalued? - sahmcapital.com
Iovance Biotherapeutics Inc. (IOVA) Peer Comparison – Compare with Others - Value Research
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Eastern Progress
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):